Literature DB >> 11442562

HIV-associated visceral leishmaniasis.

V Pintado1, R López-Vélez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11442562     DOI： 10.1046/j.1198-743x.2001.00262.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


× No keyword cloud information.
  19 in total

1.  Evaluation of a latex agglutination test (KAtex) for detection of Leishmania antigen in urine of patients with HIV-Leishmania coinfection: value in diagnosis and post-treatment follow-up.

Authors:  C Riera; R Fisa; P Lopez; E Ribera; J Carrió; V Falcó; I Molina; M Gállego; M Portús
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-12       Impact factor: 3.267

2.  Microscopy and polymerase chain reaction detection of Leishmania chagasi in the pleural and ascitic fluid of a patient with AIDS: Case report and review of diagnosis and therapy of visceral leishmaniasis.

Authors:  Ada Rs Diehl; Rodrigo P Dos Santos; Ricardo Zimmerman; Letícia P Luz; Tanara Weiss; Pedro Jacobson; Luciano Z Goldani
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-07       Impact factor: 2.471

3.  Human immunodeficiency virus and leishmaniasis.

Authors:  Navid Ezra; Maria Teresa Ochoa; Noah Craft
Journal:  J Glob Infect Dis       Date:  2010-09

4.  [HIV positive patient with pancytopenia and massive splenomegaly].

Authors:  H J Epple; G Harms; M Notter; R Husack; M Zeitz; T Schneider
Journal:  Internist (Berl)       Date:  2003-08       Impact factor: 0.743

Review 5.  The relationship between leishmaniasis and AIDS: the second 10 years.

Authors:  Jorge Alvar; Pilar Aparicio; Abraham Aseffa; Margriet Den Boer; Carmen Cañavate; Jean-Pierre Dedet; Luigi Gradoni; Rachel Ter Horst; Rogelio López-Vélez; Javier Moreno
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

6.  Parasite detection in patients with post kala-azar dermal leishmaniasis in India: a comparison between molecular and immunological methods.

Authors:  P Salotra; G Sreenivas; K R Beena; A Mukherjee; V Ramesh
Journal:  J Clin Pathol       Date:  2003-11       Impact factor: 3.411

7.  Real-time PCR assay for clinical management of human immunodeficiency virus-infected patients with visceral leishmaniasis.

Authors:  Simona Bossolasco; Giovanni Gaiera; Davide Olchini; Maurizio Gulletta; Leonardo Martello; Arabella Bestetti; Laura Bossi; Luca Germagnoli; Adriano Lazzarin; Caterina Uberti-Foppa; Paola Cinque
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

8.  Antileishmanial activity of 1,3,4-thiadiazolium-2-aminide in mice infected with Leishmania amazonensis.

Authors:  Raquel F Rodrigues; Karen S Charret; Edson F da Silva; Aurea Echevarria; Verônica F Amaral; Leonor L Leon; Marilene M Canto-Cavalheiro
Journal:  Antimicrob Agents Chemother       Date:  2008-11-17       Impact factor: 5.191

9.  Asymptomatic carriers of Leishmania infantum in patients infected with human immunodeficiency virus (HIV) in Morocco.

Authors:  M Echchakery; J Nieto; S Boussaa; N El Fajali; S Ortega; K Souhail; H Aajly; C Chicharro; E Carrillo; J Moreno; A Boumezzough
Journal:  Parasitol Res       Date:  2018-02-24       Impact factor: 2.289

Review 10.  Leishmaniasis: where are we and where are we heading?

Authors:  Santanu Sasidharan; Prakash Saudagar
Journal:  Parasitol Res       Date:  2021-04-07       Impact factor: 2.289
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.